clinicalintelpulse.theaslangroupllc.com publishes 16 machine-payable endpoints over the x402 protocol, priced from $0.02 to $0.35 per call. Each was probed directly; the response code below is what it returned.
| Endpoint | Method | Price | Probe |
|---|---|---|---|
| /api/clinical/approval-outlook | GET | $0.25 | 402 |
| /api/clinical/deal-signal | GET | $0.35 | 402 |
| /api/clinical/deal-signal-lite | GET | $0.25 | 402 |
| /api/clinical/disease-landscape | GET | $0.35 | 402 |
| /api/clinical/disease-landscape-lite | GET | $0.25 | 402 |
| /api/clinical/drug-check | GET | $0.1 | 402 |
| /api/clinical/failure-analysis | GET | $0.2 | 402 |
| /api/clinical/global-trials | GET | $0.15 | 402 |
| /api/clinical/interaction-check | GET | $0.15 | 402 |
| /api/clinical/mechanism-map | GET | $0.2 | 402 |
| /api/clinical/patient-finder | GET | $0.1 | 402 |
| /api/clinical/pipeline-scan | GET | $0.15 | 402 |
| /api/clinical/recall-check | GET | $0.1 | 402 |
| /api/clinical/sponsor-intel | GET | $0.2 | 402 |
| /api/clinical/trial-brief | GET | $0.1 | 402 |
| /api/clinical/trial-check | GET | $0.02 | 402 |
FDA/EMA drug approval probability + PDUFA calendar for a disease area — which Phase 3 drugs are most likely to win approval in 12-24 months, with mechanism, trial results, approval-probability scores …
Biotech M&A + licensing deal signal for clinical-stage drugs — Phase 2/3 assets most likely to be acquired or licensed, with acquisition targets, deal comps, transaction multiples and estimated deal v…
Deterministic preview of biotech M&A deal-signal candidates — Phase 2/3 trial counts and the industry-sponsored asset list straight off ClinicalTrials.gov, no LLM synthesis. For agents with small per-…
Competitive drug pipeline landscape for any disease — full Phase 2/3 trial map, mechanism-of-action coverage, approved drugs, PDUFA calendar, M&A activity, opportunity gaps and investment thesis. Worl…
Deterministic preview of the disease pipeline landscape — Phase 2/3 trial counts, sponsor rollup, trial-status breakdown and a sample of trials straight off ClinicalTrials.gov. No LLM synthesis. For a…
What is this medication? Plain-language explainer for any prescription or OTC drug from its FDA-approved label — what it treats, how to take it, boxed warnings, who should not take it, common and seri…
Clinical trial failure analysis for a disease area — why Phase 2/3 trials failed (wrong target, patient population, endpoint, dose, safety), failure taxonomy with percentages, phase-transition success…
Global clinical trial landscape for any disease — geographic distribution by country across WHO ICTRP registries (US, EU, China, India, Japan, Brazil, Africa and more), regulatory pathways, access gap…
Can these medications be taken together? Cross-references the FDA-approved drug-interaction and contraindication sections for 2+ drugs and flags possible interactions in plain language, with severity …
Drug mechanism-of-action + molecular target landscape for any disease — targets in active trials, approved agents by MOA, crowded vs novel mechanisms and first-in-class openings, with key publications…
Recruiting clinical trial finder for a disease or diagnosis — actively recruiting trials with plain-language summaries, eligibility (who can/cannot join), country filter, contacts and how to apply, ac…
Clinical trial pipeline scan for any disease — all active Phase 2/3 trials with trial counts, sponsor landscape, geographic distribution, mechanism breakdown and pipeline density, across 400,000+ tria…
Is my medication recalled? Checks the FDA enforcement databases (drug AND food — infant formula and supplements are filed under food) for active and past recalls, explains the recall class (I/II/III) …
Pharma/biotech company pipeline intelligence — full drug pipeline by phase, therapeutic-area coverage, FDA approval history, partnerships, competitive positioning and investment catalysts for any spon…
Clinical trial deep dive by NCT ID — full trial design, primary/secondary endpoints, enrollment status and countries, sponsor, recruitment criteria, outcomes and publications for any ClinicalTrials.go…
ClinicalTrials.gov lookup, deterministic. Answers "what is the status of NCT02142738", "recruiting phase-3 melanoma trials", "Pfizer trial pipeline". Single trial by NCT id (status, phase, sponsor, en…